Comparing neural networks in the discrimination of benign from malignant lower urinary tract lesions
Authors:
Open Access
- 1 April 1998
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 81 (4) , 574-579
Abstract
Objective: To compare the performance of two different neural networks (NNs) in the discrimination of benign and malignant lower urinary tract lesions. Materials and methods: A group of patients was evaluated, comprising 50 cases of lithiasis, 61 of inflammation, 99 of benign prostatic hyperplasia (BPH), five of in situ carcinoma, 71 of grade I transitional cell carcinoma of the bladder (TCCB), and 184 of grade II and grade III TCCB. Images of routinely processed voided urine smears were stained using the Giemsa technique and analysed using an image‐analysis system, providing a dataset of 45 452 cells. Two NN models of the back propagation (BP) and learning vector quantizer (LVQ) type were used to discriminate benign from malignant cells and lesions, based on morphometric and textural features. The data from 13 636 randomly selected cells (30% of the total data) were used as a training set and data from the remaining 31 816 cells comprised the test set. Similarly, in an attempt to discriminate patients, 30% of the cases, selected randomly, were used to train a BP and an LVQ NN, with the remaining 329 cases used for the test set. The data used for training and testing were the same for the two kinds of classifiers. Results: The two NNs gave similar results, with an overall accuracy of discrimination of ≈90.5% at the cellular level and of ≈97% for individual patients. There were no statistically significant differences between the two NNs at the cellular or patient level. Conclusions: The use of NNs and image morphometry could increase the diagnostic accuracy of voided urine cytology; despite the different nature of the two classifiers, the results obtained were very similar.Keywords
This publication has 13 references indexed in Scilit:
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990
- Enhanced Bladder Cancer Detection with the Lewis X Antigen as a Marker of Neoplastic TransformationJournal of Urology, 1990
- Detection of Malignant Cells in Voided Urine from Patients with Bladder Cancer, A Novel Monoclonal AssayJournal of Urology, 1989
- Monoclonal Antibody 486 P 3/12: A Valuable Bladder Carcinoma Marker for ImmunocytologyJournal of Urology, 1987
- Flow Cytometry Versus Urinary Cytology in the Evaluation of Patients with Bladder CancerJournal of Urology, 1986
- Exfoliative Cytology after Transurethral Resection of Superficial Bladder TumoursBritish Journal of Urology, 1985
- Monoclonal Antibodies Against Transitional Cell Carcinoma for Detection of Malignant Urothelial Cells in Bladder WashingJournal of Urology, 1985
- Computer-Based Diagnostic Analysis of Cells in the Urinary SedimentJournal of Urology, 1980
- The role of exfoliative cytology in the management of bladder carcinomaUrological Research, 1978
- Nuclear Size and Chromatin Concentration in Transitional Cell Carcinoma of the Human Urinary BladderBeiträge zur Pathologie, 1976